169 related articles for article (PubMed ID: 10709996)
21. Inhibition of collagenolytic cathepsins by beta-lactoglobulin in milk and its suppressive effect on bone resorption.
Ogawa N; Takahashi M; Ishidoh K; Katunuma N
J Nutr Sci Vitaminol (Tokyo); 2009 Jun; 55(3):264-70. PubMed ID: 19602835
[TBL] [Abstract][Full Text] [Related]
22. Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption.
Clemens JD; Herrick MV; Singer FR; Eyre DR
Clin Chem; 1997 Nov; 43(11):2058-63. PubMed ID: 9365389
[TBL] [Abstract][Full Text] [Related]
23. Species differences between human and rat in the substrate specificity of cathepsin K.
Tada S; Tsutsumi K; Ishihara H; Suzuki K; Gohda K; Teno N
J Biochem; 2008 Oct; 144(4):499-506. PubMed ID: 18664521
[TBL] [Abstract][Full Text] [Related]
24. Cathepsin k is a critical protease in synovial fibroblast-mediated collagen degradation.
Hou WS; Li Z; Gordon RE; Chan K; Klein MJ; Levy R; Keysser M; Keyszer G; Brömme D
Am J Pathol; 2001 Dec; 159(6):2167-77. PubMed ID: 11733367
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of cathepsin K reduces bone erosion, cartilage degradation and inflammation evoked by collagen-induced arthritis in mice.
Svelander L; Erlandsson-Harris H; Astner L; Grabowska U; Klareskog L; Lindstrom E; Hewitt E
Eur J Pharmacol; 2009 Jun; 613(1-3):155-62. PubMed ID: 19358841
[TBL] [Abstract][Full Text] [Related]
26. The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation.
Garnero P; Ferreras M; Karsdal MA; Nicamhlaoibh R; Risteli J; Borel O; Qvist P; Delmas PD; Foged NT; Delaissé JM
J Bone Miner Res; 2003 May; 18(5):859-67. PubMed ID: 12733725
[TBL] [Abstract][Full Text] [Related]
27. Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts.
Parikka V; Lehenkari P; Sassi ML; Halleen J; Risteli J; Härkönen P; Väänänen HK
Endocrinology; 2001 Dec; 142(12):5371-8. PubMed ID: 11713237
[TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities.
Delaissé JM; Andersen TL; Engsig MT; Henriksen K; Troen T; Blavier L
Microsc Res Tech; 2003 Aug; 61(6):504-13. PubMed ID: 12879418
[TBL] [Abstract][Full Text] [Related]
29. Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification.
Bossard MJ; Tomaszek TA; Thompson SK; Amegadzie BY; Hanning CR; Jones C; Kurdyla JT; McNulty DE; Drake FH; Gowen M; Levy MA
J Biol Chem; 1996 May; 271(21):12517-24. PubMed ID: 8647860
[TBL] [Abstract][Full Text] [Related]
30. [Cross-linked N-telopeptides of type I collagen(NTX)].
Saito S; Nakatsuka K
Nihon Rinsho; 2004 Feb; 62 Suppl 2():358-62. PubMed ID: 15035152
[No Abstract] [Full Text] [Related]
31. The S2 subsites of cathepsins K and L and their contribution to collagen degradation.
Lecaille F; Chowdhury S; Purisima E; Brömme D; Lalmanach G
Protein Sci; 2007 Apr; 16(4):662-70. PubMed ID: 17384231
[TBL] [Abstract][Full Text] [Related]
32. Complete degradation of type X collagen requires the combined action of interstitial collagenase and osteoclast-derived cathepsin-B.
Sires UI; Schmid TM; Fliszar CJ; Wang ZQ; Gluck SL; Welgus HG
J Clin Invest; 1995 May; 95(5):2089-95. PubMed ID: 7738176
[TBL] [Abstract][Full Text] [Related]
33. Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction.
Hummel KM; Petrow PK; Franz JK; Müller-Ladner U; Aicher WK; Gay RE; Brömme D; Gay S
J Rheumatol; 1998 Oct; 25(10):1887-94. PubMed ID: 9779840
[TBL] [Abstract][Full Text] [Related]
34. Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates.
Li Z; Hou WS; Brömme D
Biochemistry; 2000 Jan; 39(3):529-36. PubMed ID: 10642177
[TBL] [Abstract][Full Text] [Related]
35. Identification of peptide fragments generated by digestion of bovine and human osteocalcin with the lysosomal proteinases cathepsin B, D, L, H, and S.
Baumgrass R; Williamson MK; Price PA
J Bone Miner Res; 1997 Mar; 12(3):447-55. PubMed ID: 9076588
[TBL] [Abstract][Full Text] [Related]
36. An oral cathepsin K inhibitor ONO-5334 inhibits N-terminal and C-terminal collagen crosslinks in serum and urine at similar plasma concentrations in postmenopausal women.
Tanaka M; Hashimoto Y; Hasegawa C
Bone; 2015 Dec; 81():178-185. PubMed ID: 26188109
[TBL] [Abstract][Full Text] [Related]
37. Probing cathepsin K activity with a selective substrate spanning its active site.
Lecaille F; Weidauer E; Juliano MA; Brömme D; Lalmanach G
Biochem J; 2003 Oct; 375(Pt 2):307-12. PubMed ID: 12837132
[TBL] [Abstract][Full Text] [Related]
38. Changes in Cytokines and Aggrecan ARGS Neoepitope in Synovial Fluid and Serum and in C-Terminal Crosslinking Telopeptide of Type II Collagen and N-Terminal Crosslinking Telopeptide of Type I Collagen in Urine Over Five Years After Anterior Cruciate Ligament Rupture: An Exploratory Analysis in the Knee Anterior Cruciate Ligament, Nonsurgical Versus Surgical Treatment Trial.
Struglics A; Larsson S; Kumahashi N; Frobell R; Lohmander LS
Arthritis Rheumatol; 2015 Jul; 67(7):1816-25. PubMed ID: 25914389
[TBL] [Abstract][Full Text] [Related]
39. Erosive arthritis in a patient with pycnodysostosis: an experiment of nature.
Ainola M; Valleala H; Nykänen P; Risteli J; Hanemaaijer R; Konttinen YT
Arthritis Rheum; 2008 Nov; 58(11):3394-401. PubMed ID: 18975331
[TBL] [Abstract][Full Text] [Related]
40. Structural basis of collagen fiber degradation by cathepsin K.
Aguda AH; Panwar P; Du X; Nguyen NT; Brayer GD; Brömme D
Proc Natl Acad Sci U S A; 2014 Dec; 111(49):17474-9. PubMed ID: 25422423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
